Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05582681 · ClinicalTrials.gov registry record · Phase 4
HCV Test and Treat Utilizing Simplified HCV Patient Education
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
NCT05582681: Clinical Trial Phase 4 study, sponsored by Weill Medical College of Cornell University.
NCT05582681 is a Phase 4 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 8 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05582681, a Phase 4 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
Study Summary
The study hypothesis is that the test and treat model utilizing video-based patient education will have higher rates of hepatitis C virus (HCV) treatment initiation and treatment completion.
Interventions
- DRUG Glecaprevir and Pibrentasvir
- DIAGNOSTIC_TEST Cepheid POC HCV Viremia (RNA) test
- OTHER HCV education from a health care provider
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-11-11 |
| Est. Completion | 2024-11-22 |
| Phase | Phase 4 |
Why NCT05582681 stopped before completion
NCT05582681 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Glecaprevir and Pibrentasvir is the first listed.
NCT05582681 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05582681 about?
NCT05582681 is a clinical study titled "HCV Test and Treat Utilizing Simplified HCV Patient Education". The study hypothesis is that the test and treat model utilizing video-based patient education will have higher rates of hepatitis C virus (HCV) treatment initiation and treatment completion.
What is the current status of trial NCT05582681?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2022-11-11. Estimated completion is 2024-11-22.
What interventions are being tested in trial NCT05582681?
The interventions under investigation include: Glecaprevir and Pibrentasvir (DRUG), Cepheid POC HCV Viremia (RNA) test (DIAGNOSTIC_TEST), HCV education from a health care provider (OTHER).
Who is sponsoring clinical trial NCT05582681?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05582681's enrollment target sits among peer trials
8 1972nd of 2000 higher than 20 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI